Elkins Park, PANCT07704840Now EnrollingIRB Ready

Post-Stroke Spasticity Clinical Trial in Elkins Park, PA

Access cutting-edge post-stroke spasticity treatment through this phase 2 clinical trial at a research site in Elkins Park. Study-provided care at no cost to qualified participants.

Sponsored by Alberto Esquenazi

Quick Self-Assessment

See if you qualify for this Elkins Park location

Preparing your pre-screening questions…

Expert Care in Elkins Park

Access post-stroke spasticity specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related post-stroke spasticity treatment provided free

Apply for This Elkins Park Location

Check if you qualify for this post-stroke spasticity clinical trial in Elkins Park, PA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Elkins Park

    Convenient for PA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Elkins Park site if eligible
  4. 4Begin participation

About This Post-Stroke Spasticity Study in Elkins Park

The goal of this clinical trial is to learn if the drug BMS-986368 works to treat post stroke spasticity in adults who have had a stroke. BMS-986368 is a designed to increase natural compounds in the body that may help calm nerves that cause muscles to be tight or spasm. The study will also learn about the safety of drug BMS-986368

Sponsor: Alberto Esquenazi

Who Can Participate

Inclusion Criteria

Ischemic or hemorrhagic stroke diagnosis 4 to 18 months prior to enrollment.
History of post stroke spasticity for at least 2 months prior to Screening Visit.
Modified Ashworth Scale (mAS) score ≥2 and \<4 for affected elbow and wrist joints at Screen and Baseline Visits.
Fugl-Meyer Assessment for Upper Extremity (FMA-UE) greater than 22 at Screen and Baseline Visits
Willing to participate with no therapy additions during study duration.
Participant must be able to read, speak, and understand English usage

Exclusion Criteria

Individuals who are pregnant or breastfeeding.
Participants must not have any concomitant disease or disorder that has symptoms of spasticity or that may influence the participant's level of spasticity.
Participants must not have a history of any substance abuse disorder as defined in Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) Diagnostic Criteria for Drug and Alcohol Abuse.
Participants must not be currently taking a medication for spasticity that cannot be discontinued and washed out prior to randomization.
Participants must not have used FAAH/MAGL inhibitor medication or any cannabinoid-related products (including cannabis, cannabidiol (CBD), or tetrahydrocannabinol (THC)) within 30 days prior to randomization.
Other protocol-defined Inclusion/Exclusion criteria apply.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Elkins Park?

Yes, this clinical trial (NCT07704840) has an active research site in Elkins Park, PA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Post-Stroke Spasticity Treatment Options in Elkins Park, PA

If you're searching for post-stroke spasticity treatment options in Elkins Park, PA, this clinical trial (NCT07704840) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Elkins Park research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced post-stroke spasticity specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all post-stroke spasticity clinical trials near you to find additional studies recruiting in your area.

More Stroke Trials in Elkins Park, PA

See all stroke clinical trials recruiting in Elkins Park — not just this study.

Browse Stroke Trials in Elkins Park →

Browse More Trials by Condition

Stroke TrialsAnkylosing Spondylitis TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Elkins Park?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Elkins Park, PA